INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Focused on Fungal disease covering prominent targets and the potent compounds
Authors Name:
Anmol Pal
Unique Id:
IJSDR2303119
Published In:
Volume 8 Issue 3, March-2023
Abstract:
In individuals with immunocompromised system, fungal infection is a common problem that frequently result in high rates of morbidity and mortality. Five separate antifungal drug classes are used in current therapy, four of which concentrate on ergosterol and cell wall glucan production. However, there are several disadvantages to using the antifungals that are now on the market, including poor oral bioavailability, limited therapeutic indices, and the development of drug resistance as a result of their use. Recent improvements in the research and development of antifungal drugs can be seen in the appearance of several novel compounds that are now in various phases of development.
Keywords:
CYP51, Squalene epoxidase, Drug targets, Antifungal, Fluconazole
Cite Article:
"Focused on Fungal disease covering prominent targets and the potent compounds", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 3, page no.743 - 746, March-2023, Available :http://www.ijsdr.org/papers/IJSDR2303119.pdf
Downloads:
000337072
Publication Details:
Published Paper ID: IJSDR2303119
Registration ID:204500
Published In: Volume 8 Issue 3, March-2023
DOI (Digital Object Identifier):
Page No: 743 - 746
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn